Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sacubitril/valsartan: A practical guide.
Fonseca C, Brito D, Ferreira J, Franco F, Morais J, Silva Cardoso J; Experts opinion, endorsed by the Working Group on Heart Failure of the Portuguese Society of cardiology. Fonseca C, et al. Among authors: silva cardoso j. Rev Port Cardiol (Engl Ed). 2019 May;38(5):309-313. doi: 10.1016/j.repc.2018.10.008. Epub 2019 Jan 22. Rev Port Cardiol (Engl Ed). 2019. PMID: 30679005 Free article. Review. English, Portuguese.
Portuguese study of familial dilated cardiomyopathy: the FATIMA study.
Martins E, Silva-Cardoso J, Bicho M, Bourbon M, Ceia F, Rebocho MJ, Moura B, Fonseca C, Correia MJ, Brito D, Perdigão C, Madeira H, Abreu-Lima C. Martins E, et al. Among authors: silva cardoso j. Rev Port Cardiol. 2008 Sep;27(9):1029-42. Rev Port Cardiol. 2008. PMID: 19044174 English, Portuguese.
Effectiveness and safety of levosimendan in clinical practice.
Silva-Cardoso J, Ferreira J, Oliveira-Soares A, Martins-de-Campos J, Fonseca C, Lousada N, Ilídio-Moreira J, Rabaçal C, Damasceno A, Amorim S, Seabra-Gomes R, Ferreira R, Abreu-Lima C; PORTLAND Investigators. Silva-Cardoso J, et al. Rev Port Cardiol. 2009 Feb;28(2):143-54. Rev Port Cardiol. 2009. PMID: 19438150 Clinical Trial.
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators. McMurray JJ, et al. Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5. Eur J Heart Fail. 2013. PMID: 23563576 Free PMC article. Clinical Trial.
Angiotensin-neprilysin inhibition versus enalapril in heart failure.
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Investigators and Committees. McMurray JJ, et al. N Engl J Med. 2014 Sep 11;371(11):993-1004. doi: 10.1056/NEJMoa1409077. Epub 2014 Aug 30. N Engl J Med. 2014. PMID: 25176015 Free article. Clinical Trial.
Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators. Packer M, et al. Among authors: silva cardoso j. Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17. Circulation. 2015. PMID: 25403646 Clinical Trial.
For the improvement of Heart Failure treatment in Portugal - Consensus statement.
Posição de peritos subscrita pelo Grupo de Estudos de Insuficiência Cardíaca da Sociedade Portuguesa de Cardiologia; Núcleo de Estudos de Insuficiência Cardíaca da Sociedade Portuguesa de Medicina Interna; Colégio da Especialidade de Medicina Geral e Familiar da Ordem dos Médicos; Núcleo de Estudos de Doenças Cardiovasculares em Medicina Geral e Familiar e Núcleo de Enfermagem em Cardiologia da Sociedade Portuguesa de Cardiologia (Anexo 1); Fonseca C, Brito D, Cernadas R, Ferreira J, Franco F, Rodrigues T, Morais J, Silva Cardoso J. Posição de peritos subscrita pelo Grupo de Estudos de Insuficiência Cardíaca da Sociedade Portuguesa de Cardiologia, et al. Among authors: silva cardoso j. Rev Port Cardiol. 2017 Jan;36(1):1-8. doi: 10.1016/j.repc.2016.10.006. Epub 2016 Dec 14. Rev Port Cardiol. 2017. PMID: 27988232 Free article. English, Portuguese.
Neurohormonal modulation: The new paradigm of pharmacological treatment of heart failure.
Silva-Cardoso J, Brás D, Canário-Almeida F, Andrade A, Oliveira L, Pádua F, Fonseca C, Bragança N, Carvalho S, Soares R, Santos JF. Silva-Cardoso J, et al. Rev Port Cardiol (Engl Ed). 2019 Mar;38(3):175-185. doi: 10.1016/j.repc.2018.10.011. Epub 2019 Apr 24. Rev Port Cardiol (Engl Ed). 2019. PMID: 31029493 Free article. Review. English, Portuguese.
118 results